EUVIMEDAvasta EUVIMED
Kontrollierte klinische Studie

Intratympanic Botulinum Toxin Injection as a New Therapeutic Modality for Middle Ear Myoclonic Tinnitus

Jung M Park iD, Min J Kim, Jae S Han, So Y Park, Shi N Park iD

Otolaryngology–Head and Neck Surgery · 2023

DOI: 10.1002/ohn.256 ↗

At a glance

Kontrollierte klinische Studie in Otolaryngology–Head and Neck Surgery, 2023. Written by Jung M Park and 4 co-authors. Institution: Department of Otorhinolaryngology-Head and Neck Surgery, Gangneung Asan Hospital, College of Medicine University of Ulsan, Gangneung, Republic of Kor…. Major MEDLINE topics: Tinnitus, Botulinum Toxins, Type A. Cited 8 times so far (Crossref); 20 references.

AbstraktSubjectsBibliograafilised andmedCiteRelated studies

Abstract (original language)

Objective

Middle ear myoclonic tinnitus (MEMT) is a disease caused by myoclonus or abnormal contractive movement of middle ear muscles (MEMs). This translational study was conducted to propose intratympanic botulinum toxin (IT‐BTX) injection as a new therapeutic modality to treat MEMT. Study Design Animal experiment and nonrandomized controlled clinical trial.

Setting

Laboratory and medical center of an academic tertiary medical institution.

Methods

For the animal study, male Sprague‐Dawley rats were divided into 4 subgroups according to the sacrificing day after IT‐BTX injection. After initial hearing tests, randomly assigned experimental ears were intratympanically injected with 1 unit/100 μL of BTX‐A, whereas control ears were injected with normal saline. Changes in the hearing thresholds, morphometry of the cochleae, electron microscopy study, and immunofluorescence analysis of MEMs were evaluated. For the human study, 10 intractable MEMT patients were enrolled. The hearing thresholds and the degree of tinnitus distress were observed for changes after IT‐BTX injection. All patients were followed up for 3 months.

Results

As for the animal study, there were no significant changes in hearing thresholds and cochlear morphologies in all 4 subgroups of the rats. Significant MEM degenerations and immuno‐detection of cleaved synaptosome‐associated protein of 25 kDa (cSNAP‐25) indicated the efficacy of IT‐BTX. MEMT patients enrolled for the pilot clinical trial showed statistically significant improvement in tinnitus after IT‐BTX injection. No major complications were noted.

Conclusion

The new therapeutic modality of IT‐BTX injection for the treatment of MEMT seems highly promising with an excellent result.

Subjects

MeSH terms (MEDLINE)

TinnitusBotulinum Toxins, Type AHumansMaleRatsAnimalsRats, Sprague-DawleyEar, MiddleHearingTreatment Outcome

Author keywords

botulinum toxinsearinjectionintratympanicmiddlemyoclonustinnitus

Substances

Botulinum Toxins, Type A

Authors and institutions

  • Department of Otorhinolaryngology-Head and Neck Surgery, Gangneung Asan Hospital, College of Medicine University of Ulsan, Gangneung, Republic of Korea.
  • Department of Otolaryngology-Head and Neck Surgery, Seoul St Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Department of Otolaryngology-Head and Neck Surgery, Yeouido St Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

ORCID profiles: Jung M Park, Shi N Park

Cite

APA

Park, J. M., Kim, M. J., Han, J. S., Park, S. Y., & Park, S. N. (2023). Intratympanic Botulinum Toxin Injection as a New Therapeutic Modality for Middle Ear Myoclonic Tinnitus. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.256

Vancouver

Park JM, Kim MJ, Han JS, Park SY, Park SN. Intratympanic Botulinum Toxin Injection as a New Therapeutic Modality for Middle Ear Myoclonic Tinnitus. Otolaryngology–Head and Neck Surgery. 2023. doi:10.1002/ohn.256

BibTeX
@article{Park2023,
  author = {Park, Jung M and Kim, Min J and Han, Jae S and Park, So Y and Park, Shi N},
  title = {Intratympanic Botulinum Toxin Injection as a New Therapeutic Modality for Middle Ear Myoclonic Tinnitus},
  journal = {Otolaryngology–Head and Neck Surgery},
  year = {2023},
  doi = {10.1002/ohn.256}
}
Start for free →